Ginsenoside Rg1 Regulates Liver Lipid Factor Metabolism in NAFLD Model Rats

[Image: see text] To establish the molecular mechanism of ginsenoside Rg1 in nonalcoholic fatty liver disease (NAFLD), Sprague Dawley (SD) rats (180–220 g) were randomly divided into a control group, model group, ginsenoside Rg1 low-dose group (30 mg/(kg day)), high-dose (60 mg/(kg day)) group, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Yunhe, Gu, Danshan, Peng, Jianzhi, Jiang, Kerong, Li, Zhigang, Shi, Jing, Yang, Shikun, Li, Shude, Fan, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241038/
https://www.ncbi.nlm.nih.gov/pubmed/32455208
http://dx.doi.org/10.1021/acsomega.0c00529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241038/
https://www.ncbi.nlm.nih.gov/pubmed/32455208
http://dx.doi.org/10.1021/acsomega.0c00529

Ejemplares similares